Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Philipp Oster"'
Autor:
Himanshu Dubey, Philipp Oster, Mir Sohail Fazeli, Sandra Guedes, Paul Serafini, Lisa Leung, Amine Amiche
Publikováno v:
International Journal of Infectious Diseases, Vol 119, Iss , Pp 1-9 (2022)
Objectives: To describe risk factors (RFs) and quantify their effects in invasive meningococcal disease (IMD) and associated mortality across all age groups based on the available published literature. Methods: A systematic literature review (SLR) wa
Externí odkaz:
https://doaj.org/article/47a944aa3af94220bb0aaedbb92e4cfc
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
This 2-stage Phase III study (NCT04142242) of a recently licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) assessed the safety and immunogenicity of a booster dose in older adults (≥59 years) primed with either MenAC
Externí odkaz:
https://doaj.org/article/f91a6c57eba94f3bab8bd8df370609b3
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-20 (2022)
Abstract Background Neisseria meningitidis is an encapsulated Gram-negative diplococcus that asymptomatically colonises the upper respiratory tract in up to 25% of the population (mainly adolescents and young adults). Invasive meningococcal disease (
Externí odkaz:
https://doaj.org/article/a094a3edd9c3494aa5e3cf25c97a9140
Autor:
Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum, Philipp Oster
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
MenACYW-TT (MenQuadfi®) is a quadrivalent meningococcal tetanus toxoid conjugate vaccine licensed in Europe for use in individuals ≥12 months. This study assessed whether serogroup C immune responses with MenACYW-TT were at least non-inferior, or
Externí odkaz:
https://doaj.org/article/f8fdf994f438443daff54e11407cc4ab
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Vaccination offers the best way to prevent invasive meningococcal disease (IMD). As demonstrated in countries with national immunization programs (NIPs) against IMD, meningococcal conjugate vaccines have contributed to significant declines in inciden
Externí odkaz:
https://doaj.org/article/6a2523a28368416cb2c7cd3c9c925ee4
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 3, Pp 919-926 (2021)
Meningococcal serogroups A and C cause significant numbers of cases in China. The Sanofi Pasteur meningococcal polysaccharide A + C vaccine (Men-AC) was licensed in China in 1995. Immunogenicity and safety of a single dose of Men-AC against a similar
Externí odkaz:
https://doaj.org/article/8db6f1d5c0f64e97bd33f6de30094c29
Autor:
Heun Choi, Hyuk Min Lee, Woonji Lee, Jun Hyoung Kim, Hye Seong, Jung Ho Kim, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Joon-Sup Yeom, Kyungwon Lee, Hee Soo Kim, Philipp Oster, Jun Yong Choi
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0244716 (2021)
University students, especially those living in dormitories, are known to have a high risk of invasive meningococcal disease. We performed a longitudinal study to investigate the change in Neisseria meningitidis carriage rates and identify the risk f
Externí odkaz:
https://doaj.org/article/f673e9ffecc4439487b925b1c62ecdf6
Autor:
Dong Soo Kim, Min Ja Kim, Sung-Ho Cha, Hwang Min Kim, Jong-Hyun Kim, Kwang Nam Kim, Jin-Soo Lee, Jun Yong Choi, Valérie Bosch Castells, Hee Soo Kim, Joon Bang, Philipp Oster
Publikováno v:
International Journal of Infectious Diseases, Vol 45, Iss C, Pp 59-64 (2016)
Objectives: To assess the safety and immunogenicity of a meningococcal polysaccharide diphtheria toxoid conjugate vaccine (MenACYW–D) in a Korean population. Methods: This was a phase III, blind-observer, controlled study in which participants aged
Externí odkaz:
https://doaj.org/article/ce3d6e4f4ffc4412bc398f4ebd420fb8
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 25, Iss 4, Pp 211-216 (2014)
OBJECTIVES:To describe the immunogenicity and safety of a two-dose series of a quadrivalent meningococcal (serogroups A, C, Y and W) polysaccharide diphtheria toxoid conjugate vaccine (MenACYW-D) administered to toddlers.
Externí odkaz:
https://doaj.org/article/fa6e8476bfd842a7849473c11c31c7c4
Autor:
Johannes Elias, Leo M. Schouls, Ingrid van de Pol, Wendy C. Keijzers, Diana R. Martin, Anne Glennie, Philipp Oster, Matthias Frosch, Ulrich Vogel, Arie van der Ende
Publikováno v:
Emerging Infectious Diseases, Vol 16, Iss 3, Pp 464-472 (2010)
Emergence of serogroup B meningococci of clonal complex sequence type (ST) 41/44 can cause high levels of disease, as exemplified by a recent epidemic in New Zealand. Multiplication of annual incidence rates (3.1 cases/100,000 population) of meningoc
Externí odkaz:
https://doaj.org/article/d7496c4f41fb410f912236aa0b96486f